Marex (MRX) President Van Den Born Simon Sells $1.1M of Stock

Simon Van Den Born, President of Marex Group, sold over 15,000 shares in a planned transaction.

Reviewed by automated data checks against the source filing. How we make and check alerts

Van Den Born Simon, President at Marex Group Limited ($MRX), sold 15,272 shares at an average price of $72.04, worth about $1.10 million, on October 12, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.

Since the trade, $MRX is down 2.5% to date (from the $72.29 close on Oct 12, 2026).

Find the original: MRX Form 4 filings on SEC EDGAR

MRX Marex Group Limited
$70.50 +87.55% year to date
Daily close · Oct 16, 2026

Key Points

  • On October 12, 2026, Simon Van Den Born sold 15,272 shares of Marex Group Limited for about $1.1 million at a price of $72.04 per share.
  • The stock recently traded around $70.49, which is below its 50-day moving average of $71.45 and 10.9% under its 52-week high of $79.11.
  • Marex Group has a market cap of approximately $5.1 billion, a P/E ratio of 14.24, and a dividend yield of 0.89%.

Get $MRX trade alerts by text

We text you when insiders, Congress or big funds trade $MRX. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Marex Group Limited alert may contain errors. Disclosures

Simon Van Den Born, President of Marex Group Limited (MRX) on the NasdaqGS, sold 15,272 shares on October 12, 2026, for approximately $1.1 million at a price of $72.04 per share. This was a planned transaction, reflecting his ongoing management of personal holdings.

Inside Van Den Born's Trade

Van Den Born's sale of 15,272 shares represents a significant transaction within his role at Marex Group. The sale took place at a price of $72.04 per share, totaling about $1,100,183.66 in value. This transaction follows a similar pattern of insider selling at Marex, as noted in previous trades by other executives.

Other Institutional Activity in Marex Group

FMR, LLC increased its stake in Marex Group by 1,886,526 shares, bringing its total to 5,368,485 shares valued at about $378.5 million. Price (T.Rowe) Associates Inc added 3,017,286 shares, resulting in a total of 4,923,341 shares worth approximately $347.1 million. Blackrock Inc. grew its holdings by 204,974 shares, ending with 4,594,149 shares valued at about $323.9 million. In contrast, Capital International Investors reduced its stake by 223,577 shares, now holding 3,264,364 shares worth about $230.1 million. AllianceBernstein L.P. increased its position by 870,272 shares, totaling 2,600,436 shares valued at approximately $183.3 million.

Marex Group Limited Stock Down 2.5%

As of October 16, 2026, Marex Group's stock was recently trading around $70.49, which is below its 50-day moving average of $71.45. The shares are also 10.9% lower than their 52-week high of $79.11, but remain significantly above the 52-week low of $29.83, showing resilience in a fluctuating market.

Recent Earnings

Marex Group reported trailing twelve-month revenue of approximately $3.49 billion, with an earnings per share (EPS) of $4.95. The company has shown a revenue growth of 32.1% year-over-year and a net margin of 12.2%. The next earnings report is scheduled for November 5, 2026.

Dividend

Marex Group pays an annual dividend of $0.64 per share, leading to a dividend yield of 0.89%. The dividend payout ratio stands at 12.3%, indicating a balanced approach to returning value to shareholders while maintaining growth.

Insider Buying and Selling at Marex Group Limited

On the same day as Van Den Born's sale, Paolo Roberto Tonucci, an officer at Marex Group, sold 16,666 shares, also valued at over $1 million. This activity suggests a broader trend of insider selling among the company's leadership.

Analysts Set New Price Targets

Analysts have maintained positive ratings for Marex Group, with UBS maintaining a Buy rating and raising its price target to $90. Barclays also maintains an Overweight rating with a target of $92. The consensus target price among analysts is $81.88, reflecting optimism about the company's future performance.

About Marex Group

Marex Group Limited is a financial services platform based in London, providing liquidity, market access, and infrastructure services in the commodity and financial markets. With a strong presence in the UK and the US, the company operates in several segments, including Clearing, Agency and Execution, and Market Making.

Bottom Line

Investors should keep an eye on Marex Group's upcoming earnings report on November 5, 2026, and monitor any further insider activity. With a solid market cap and positive analyst ratings, the company appears to be positioned well in its sector.

Source: Van Den Born Simon's Form 4 filing on $MRX (Oct 12, 2026). Find the original filing: MRX Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $MRX trade alerts by text